MRI signs of acute brain hemorrhage in microangiopathy patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study reviews how gadolinium-enhanced MRI—looking for ‘spot signs’—appears during the acute phase of lobar cerebral hemorrhages. It uses existing patient data from Nîmes University Hospital to link MRI findings with subsequent imaging changes. No interventions are performed; researchers focus on imaging patterns and their potential to identify higher-risk subgroups. The goal is to lay groundwork for selecting patients who might benefit from future targeted therapies. Findings could improve understanding of hemorrhage evolution and help inform future trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with acute cerebral hematomas from existing databases of cerebral amyloid angiopathy and hypertensive microangiopathy managed at Nîmes University Hospital;
* Patients who have undergone a follow-up cerebral CT scan in the event of worsening or for follow-up.

Exclusion Criteria:

* Patient refusing to participate

Where it's running

• CHU de Nîmes
  Nîmes, Gard, France Recruiting

Study contacts

• Study coordinator: Teodora PARVU
• Email: teodora.parvu@chu-nimes.fr
• Phone: 04.66.68.32.61

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Rural Telemedicine-Enabled Care to Prevent Stroke in Older Adults in China

  A telemedicine-supported care model led by rural doctors will be tested to see if it can reduce stroke and heart problems in adults 65+ living in rural China.

  Recruiting at 2 sites Jiangsu Province (Suqian) Hospital · Suqian, Jiangsu and 1 other locations · NCT07628283

• Evaluating brain blood flow using contrast-enhanced ultrasound

  This study is testing a new ultrasound method to see if it can help doctors check blood flow in the brains of patients with recent brain injuries.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT05893407

• Treatment for neurologic disorders using stem cells

  This study is testing whether using stem cells from patients' own bone marrow can help improve brain and nerve function in people with serious neurologic disorders that don't respond well to regular treatments.

  Recruiting at 3 sites MD Stem Cells · Westport, Connecticut and 2 other locations · NCT02795052

• Maximal Medical Care for Intracerebral Hemorrhage (ICH) – Pilot

  This pilot test checks whether a maximal medical care bundle for ICH patients is feasible and safe to use in the first 72 hours.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT06648369

• Understanding the impact of brain swelling in stroke patients

  This study is trying to understand how brain swelling affects people who have had a severe type of stroke to see if it can help improve their treatment.

  Recruiting University Hospital, Lille · Lille · NCT04621357

• Minimally invasive treatment for brain hemorrhage compared to standard care

  This study is testing a new, less invasive treatment for brain bleeding to see if it works better than standard care for patients who arrive at the emergency room with a significant hemorrhage.

  Recruiting at 7 sites University of Melbourne · Newcastle, New South Wales and 12 other locations · NCT04434807

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.